Related Experiment Video
Updated: May 10, 2026
06:20
Assessment of the Immunomodulatory Properties of Human Mesenchymal Stem Cells (MSCs)
Published on: December 24, 2015
Immune responses after mesenchymal stem cell implantation.
1Division of Cardiac Surgery, Health Sciences North Sudbury, Greater Sudbury, ON, Canada.
Methods in Molecular Biology (Clifton, N.J.)
|June 29, 2013
Summary
Mesenchymal stromal cells (MSCs) show unique immune tolerance, suggesting their potential as universal donor cells for cardiac repair. This could overcome immune rejection issues in stem cell transplantation for myocardial damage.
Area of Science:
- Cardiovascular biology
- Immunology
- Regenerative medicine
Background:
- Stem cell transplantation is a key strategy for cardiac repair after myocardial damage.
- Autologous cells are typically used to prevent immune rejection.
- Mesenchymal stromal cells (MSCs) have emerged as a potential alternative due to their unique properties.
Purpose of the Study:
- To review the immunologic mechanisms behind MSC immune tolerance.
- To explore the potential of MSCs as universal donor cells for cardiac applications.
Main Methods:
- Review of in vitro and in vivo studies on MSC immunomodulation.
- Analysis of rodent and human MSC transplant models.
- Examination of underlying immunological mechanisms.
Main Results:
- MSCs demonstrate significant immune tolerance in various transplant models.
- Evidence suggests MSCs can evade immune detection and rejection.
- The mechanisms facilitating this immune tolerance are being elucidated.
Conclusions:
- MSCs possess inherent immune-privileged characteristics.
- Their immune tolerance supports their use as allogeneic "universal donor cells".
- This facilitates broader application of stem cell therapy in cardiac regenerative medicine.
Related Concept Videos
01:40Cell-mediated Immune Responses
Overview
01:19Mesenchymal Stem Cells
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...